Article Text

Download PDFPDF
Diabetic heart disease
Diabetes, incretin hormones and cardioprotection

Statistics from Altmetric.com

Footnotes

  • Contributors AM wrote the manuscript in its entirety. All authors were involved in conception, design, appraising and revising the manuscript critically for important intellectual content. All authors have seen and given approval of the final version of the manuscript for submission.

  • Funding MSM and AM are supported by the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's & St Thomas’ NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. AM also acknowledges financial support from the British Heart Foundation via a Clinical Research Training Fellowship (grant number FS/11/70/28917).

  • Competing interests In compliance with EBAC/EACCME guidelines, all authors participating in Education in Heart have disclosed potential conflicts of interest that might cause a bias in the article. DMY reports receiving research grant support from Bristol-Myers Squibb and Merck Sharp and Dohme to investigate the potential cardioprotective effect of incretins in animal models. AM, SRR, BJG and MSM: none declared.

  • Provenance and peer review Commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles